Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia
Comparison of Two Surgical Approaches in the Treatment of Cervical Dysplasia: Complete Removal of the Transformation Zone (LLETZ) Versus Isolated Resection of the Colposcopically Visible Lesion (LEEP)
Ruhr University of Bochum
206 participants
Jun 7, 2021
INTERVENTIONAL
Conditions
Summary
Cervical dysplasia is the precursor of cervical cancer. LEEP and LLETZ are standard surgical procedures to treat cervical dysplasia. There is no direct head-to-head comparison between LEEP and LLETZ in the literature regarding oncologic safety, for which complete resection of the dysplastic lesion (so-called 'in-sano resection') is the most appropriate postoperative surrogate parameter. Further clinical studies are therefore useful to optimize surgical therapy for cervical dysplasia. The primary objective of the present study is to compare LLETZ (resection of the dysplastic lesion including the transformation zone) with targeted resection of the colposcopically conspicuous lesion only (LEEP) and to compare it with regard to oncological safety (defined as non-in-sano rate).
Eligibility
Inclusion Criteria3
- Histologically confirmed High Grade Squamous Intraepithelial Lesion (HSIL)
- Colposcopically visible lesion
- No therapy of the disease so far
Exclusion Criteria5
- Pregnancy of the patient at/after inclusion in the study; pregnancy after conization and before the control after 6 months is possible and does not lead to exclusion from the study.
- Taking immunosuppressive drugs (incl. glucocorticoids)
- Known HIV positivity
- Malignant disease requiring treatment
- Unsatisfactory colposcopy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
LLETZ is one of several possible surgical interventions for treating cervical dysplasia. The transformation zone of the cervix is completely removed
LEEP is one of several possible surgical interventions for treating cervical dysplasia. Only the dysplastic lesion is removed without removing the whole transformation zone.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04772937